Manhattan Scientifics Acquires 43 Million MHTX Common Shares from Lancer Fund Trustee

Click here to view the printer friendly PDF version of this press release

New York City-- Manhattan Scientifics Inc. (MHTX) announced today that, in a court-approved transaction, it has acquired all 43 million shares and 10 million warrants of MHTX held by the SEC appointed Lancer Funds Trustee. Manhattan Scientifics completed a $1.1 million Private Placement, a portion of which enabled this transaction, thereby removing this overhang from the market.

The company is completing its audit and intends to regain its status as a fully reporting Bulletin Board listed company.

The foregoing press release contains forward-looking statements which are subject to risk and uncertainty which may be beyond the company's control..

About Manhattan Scientifics Manhattan Scientifics, Inc., http://www.mhtx.com, is located in Montreal Canada, New Mexico and New York City. It is developing and plans to acquire technologies in a variety of environmentally friendly energy and other people-friendly industries.

The foregoing press release contains forward-looking statements which are subject to risk and uncertainty which may be beyond the company’s control.

Copies of Manhattan Scientifics’ press releases and related investor information may be found at http://www.hawkassociates.com and http://www.americanmicrocaps.com.

An investment profile about Manhattan Scientifics may be found at http://www.hawkassociates.com/mhtx/profile.htm.

Executive Contacts:
Manny Tsoupanarias
Email: mtsoupanarias@manhattan-scientifics.com
Phone: 918-919-0370

For Investor Relations contact MHTX Chairman Emeritus Marvin Maslow
Email: marvin@marvinmaslow.com
Phone: 917-923-3300

Manhattan Scientifics Inc. © 2008 | Disclaimer